Canon U.S.A. announced Thursday it has made a strategic investment in Ottawa-based Spartan Bioscience Inc. to fund research and development of new diagnostic testing products.
Canon’s wholly-owned subsidiary, Canon BioMedical Inc. is looking into ways it can work with Spartan on other products like rapid genetic testing.
“We are excited to continue our efforts as we move into new markets for rapid genetic testing,” Spartan CEO Paul Lem said in a statement. “Working with Canon will help accelerate our progress in the future.”
OBJ360 (Sponsored)
![Chef Yannick Anton of the Cordon Bleu](https://assets.obj.ca/2024/06/Chef-Yannick_20240625_104056_0000-300x169.jpg)
Bringing France to Ottawa: Chef Yannick Anton recognized for contributions to the capital food scene
At the age of 14 in Nice, France, Yannick Anton was asked to choose a path for his career. After a few cooking classes in school, and seeing his grandfather
![uOttawa Faculty of Engineering](https://assets.obj.ca/2024/06/Engineering-20240624_114812_0000-300x169.jpg)
uOttawa’s Faculty of Engineering is filling skill gaps in the tech industry
University of Ottawa’s Faculty of Engineering has been preparing for this moment for years, proactively adapting its curriculum to meet the evolving demands of the technology sector and the Ottawa
Seymour Liebman, who currently sits on Canon BioMedical’s board of directors will also join Spartan’s board.
“Spartan’s goals align with our mission to provide enhanced diagnostic testing systems that can help improve human health worldwide,” Mr. Liebman said in a statement.
Terms of the investment were not disclosed.